Decarboxylative Elimination of <i>N</i>-Acyl Amino Acids via Photoredox/Cobalt Dual Catalysis
作者:Kaitie C. Cartwright、Jon A. Tunge
DOI:10.1021/acscatal.8b03282
日期:2018.12.7
A dual-catalytic strategy for the synthesis of enamides and enecarbamates directly from easily accessible and inexpensive amino acids has been realized. This mild and efficient protocol makes use of an organic photoredox catalyst and a cobaloxime catalyst to achieve decarboxylative elimination using hydrogen evolution to drive the oxidation. Thus, the reaction occurs without a stoichiometric oxidant
AMINO ACID AMIDES OF 5-AMINO-1,3,4-THIADIAZONES AND THEIR USE AS INHIBITORS FOR MATRIX METALLOPROTEINASES
申请人:PROSCRIPT, INC.
公开号:EP0845002A2
公开(公告)日:1998-06-03
US5677282A
申请人:——
公开号:US5677282A
公开(公告)日:1997-10-14
[EN] AMINO ACID AMIDES OF 5-AMINO-1,3,4-THIADIAZONES AND THEIR USE AS INHIBITORS FOR MATRIX METALLOPROTEINASES<br/>[FR] AMIDES AMINOACIDES DE 5-AMINO-1,3,4-THIADIAZONES ET LEUR UTILISATION COMME INHIBITEURS DES METALLOPROTEINASES MATRICIELLES
申请人:——
公开号:WO1996040745A2
公开(公告)日:1996-12-19
[EN] Amino acid amides of 5-amino-1,3,4-thiadiazole-2-thione are disclosed. These compounds inhibit matrix metalloproteinase enzymes and cartilage degradation. Methods of treating diseases caused by over-activity of matrix metalloproteinases, such as osteoarthritis and rheumatoid arthritis, are also disclosed. [FR] L'invention concerne des amides aminoacides de 5-amino-1,3,4-thiadiazole-2-thione. Ces composés inhibent les métalloprotéinases matricielles et la dégradation du cartilage. Sont également décrits des procédés pour traiter des maladies provoquées par l'hyperactivité des métalloprotéinases matricielles, telles que l'arthrose et la polyarthrite rhumatoïde.
[EN] The use of N5-substituted 5-amino-1,3,4-thiadiazole-2-thiols as metalloproteinases to inhibit matrix metalloproteinase enzymes and cartilage degradation is disclosed. Methods of treating diseases caused by over-activity of matrix metalloproteinases, such as osteoarthritis and rheumatoid arthritis, are also disclosed. [FR] L'invention concerne l'utilisation de 5-amino-1,3,4-thiadiazole-2-thiols à substitution N5 utilisés en tant que métalloprotéinases pour inhiber les enzymes métalloprotéinases matricielles et empêcher la dégradation du cartilage. L'invention concerne également des méthodes de traitement de maladies provoquées par une suractivité de métalloprotéinases matricielles, telles que l'ostéoarthrite et la polyarthrite rhumatoïde.